Low Cancer Prevalence Reported Following Fibroid Removal

Share this content:
The use of power morcellation to remove often-painful fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen.
The use of power morcellation to remove often-painful fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen.

HealthDay News -- The use of power morcellation to remove often-painful fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen, but a new study suggests the likelihood is low. 

Researchers called the findings, reported online in JAMA Oncology, "reassuring."

The new study was done to get a handle on how many women having fibroids removed -- but not the uterus -- might have hidden cancer, lead researcher Dr. Jason Wright, chief of gynecologic oncology at Columbia University, in New York City, explained to HealthDay. His team looked at records for 41,777 U.S. women who had fibroids surgically removed between 2006 and 2012. A power morcellator was used in 3,220 cases.

Of those women who were treated with a morcellator, three were later found to have uterine cancer -- a rate of one in 1,073 patients. By comparison, the odds of uterine cancer were one in 528 among women who had fibroids removed without the device. As expected, the likelihood of a hidden cancer increased with age: Of women younger than 40 who had power morcellation, none were found to have uterine cancer; the rate increased to almost 1 percent among women in their 50s.

"Overall, the risk is low, and I think that's reassuring," Wright said. He noted that the results are also in line with the FDA's recommendations for older and younger women.

Reference

1. Wright JD, et al. JAMA Onc. 2015. DOI: 10.1001/jamaoncol.2014.206rence 

You must be a registered member of Clinical Pain Advisor to post a comment.